Altered vascular homeostasis in chronic kidney disease

Area of Science:

• Nephrology
• Vascular Biology
• Biomarker Research

Background:

• Current chronic kidney disease (CKD) treatments often lead to declining renal perfusion and end-stage renal disease.
• Renal microvascular disease progression is a potential driver of renal failure in CKD patients.
• Understanding microvascular homeostasis mechanisms in CKD is crucial for therapeutic development.

Purpose of the Study:

• To investigate the mechanisms of microvascular homeostasis in patients with moderately impaired renal function due to CKD.
• To assess biomarkers of vascular injury and repair in the context of CKD.
• To correlate vascular homeostasis markers with treatment outcomes in CKD.

Main Methods:

• Measurement of circulating endothelial cells (CECs) as a marker of vascular injury.
• Quantification of vascular repair biomarkers including vascular endothelial growth factor (VEGF), angiopoietin-1, tie-2, angiopoietin-2, and VEGF-R2.
• Analysis of these biomarkers in CKD patients with moderately impaired renal function.

Main Results:

• CKD patients exhibited elevated levels of circulating endothelial cells, indicating increased vascular injury.
• Deficiencies in pro-angiogenic factors (VEGF, angiopoietin-1) were observed.
• Elevated levels of anti-angiogenic factors (angiopoietin-2, VEGF-R2) suggest a defective vascular repair response.

Conclusions:

• In moderately impaired CKD, heightened vascular injury occurs alongside a compromised vascular repair capacity.
• This imbalance between injury and repair may explain the limited efficacy of current CKD treatments.
• Implementing therapeutic strategies at earlier stages of CKD is recommended to address microvascular dysfunction.